Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries

Challenges for Plasma-Derived Medicinal Products

(2023) Paul F.W. Strengers   TRANSFUSION MEDICINE AND HEMOTHERAPY

Shortage of plasma-derived products: a looming crisis?

(2022) Mischa Li Covington et al.   BLOOD

Stepwise access to safe plasma proteins in resource‐constrained countries: Local production and pathways to fractionation—Report of an International Society of Blood Transfusion Workshop

(2022) Thierry Burnouf et al.   VOX SANGUINIS

Plasma procurement and plasma product safety in light of the COVID ‐19 pandemic from the perspective of the plasma industry

(2022) Peter L. Turecek et al.   VOX SANGUINIS

Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop

(2022) Thierry Burnouf et al.   BIOLOGICALS

Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years

(2022) Glenn F Pierce et al.   Lancet Haematology

Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma

(2021) Shaukat Ali et al.   Immunotherapy

Effects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro

(2021) Kimberly A. Thomas et al.   TRANSFUSION

Overcoming the challenges of treating hemophilia in resource-limited nations: a focus on medication access and adherence

(2021) Kanjaksha Ghosh et al.   Expert Review of Hematology

Global immunoglobulin supply: steaming towards the iceberg?

(2020) Johan Prevot et al.   Current Opinion in Allergy and Clinical Immunology

Plasma fractionation in countries with limited infrastructure and low-/medium income: How to move forward?

(2019) Thierry Burnouf et al.   TRANSFUSION AND APHERESIS SCIENCE

Do we still need cryoprecipitate? Cryoprecipitate and fibrinogen concentrate as treatments for major hemorrhage — how do they compare?

(2018) Alex Novak et al.   Expert Review of Hematology

Bitter progress in the treatment of haemophilia A in low-income countries

(2018) Jean-Claude Faber et al.   Lancet Haematology

A randomized multicenter study: safety and efficacy of mini-pool intravenous immunoglobulin versus standard immunoglobulin in children aged 1-18 years with immune thrombocytopenia

(2017) Mohsen Elalfy et al.   TRANSFUSION

Plasma is a strategic resource

(2016) Paul F.W. Strengers et al.   TRANSFUSION

Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation

(2016) C. K. Okerberg et al.   VOX SANGUINIS

Minipool Caprylic Acid Fractionation of Plasma Using Disposable Equipment: A Practical Method to Enhance Immunoglobulin Supply in Developing Countries

(2015) Magdy El-Ekiaby et al.   PLoS Neglected Tropical Diseases

Pharmacokinetic study of minipooled solvent/detergent-filtered cryoprecipitate factor VIII

(2011) M. EL-EKIABY et al.   HAEMOPHILIA

Plasma fractionation issues

(2009) Albert Farrugia et al.   BIOLOGICALS

Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system

(2009) M. El-Ekiaby et al.   TRANSFUSION MEDICINE